Heska - 24 Year Stock Price History | HSKA

Historical daily share price chart and data for Heska since 1997 adjusted for splits. The latest closing stock price for Heska as of September 16, 2021 is 254.35.
  • The all-time high Heska stock closing price was 274.20 on August 24, 2021.
  • The Heska 52-week high stock price is 275.94, which is 8.5% above the current share price.
  • The Heska 52-week low stock price is 93.90, which is 63.1% below the current share price.
  • The average Heska stock price for the last 52 weeks is 182.41.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Heska Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2021 207.5110 143.9300 274.2000 143.9300 254.3500 74.63%
2020 97.8642 97.0100 151.1800 52.1700 145.6500 51.81%
2019 82.3959 90.5600 99.3400 64.1700 95.9400 11.43%
2018 92.7229 79.7500 113.3100 58.3600 86.1000 7.34%
2017 92.7294 71.5500 110.2400 71.5500 80.2100 12.03%
2016 44.5886 36.9600 72.8500 27.0500 71.6000 85.11%
2015 29.0280 18.0300 39.7600 16.3200 38.6800 113.35%
2014 11.9812 8.7300 18.1300 8.6300 18.1300 107.91%
2013 7.4188 8.2800 9.3000 5.1800 8.7200 7.65%
2012 9.7663 7.3500 12.8400 7.0500 8.1000 10.96%
2011 7.6432 4.8410 10.1900 4.6610 7.3000 47.18%
2010 6.1338 5.8000 9.6990 4.1500 4.9600 -5.97%
2009 3.7369 2.4490 5.9500 1.7000 5.2750 110.92%
2008 11.0439 21.0000 21.0000 1.8100 2.5010 -86.33%
2007 20.1042 17.2000 29.0000 15.6000 18.3000 8.93%
2006 13.9996 13.5000 18.6000 10.1000 16.8000 27.27%
2005 9.3256 11.8000 13.5000 5.6000 13.2000 12.92%
2004 17.8213 23.0000 32.4000 10.0000 11.6900 -49.15%
2003 14.9321 3.8000 34.8000 3.4000 22.9900 556.86%
2002 6.8878 11.0000 13.5000 3.0000 3.5000 -65.00%
2001 10.4333 7.5000 14.6900 5.3000 10.0000 45.45%
2000 25.8963 27.5000 53.1300 6.8750 6.8750 -69.44%
1999 32.5702 42.5000 58.7500 15.6300 22.5000 -49.30%
1998 98.2546 122.5000 165.0000 32.5000 44.3800 -64.15%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $2.701B $0.197B
Heska Corporation sells advanced veterinary diagnostic and specialty products. Heska's state-of-the-art offerings include blood testing instruments and supplies, digital imaging products, software and services, data services, allergy testing and immunotherapy, and single-use offerings such as in-clinic diagnostic tests and heartworm preventive products. The Company's core focus is on the canine and feline markets where it strives to provide high value products and unparalleled support to veterinarians.
Stock Name Country Market Cap PE Ratio
Moderna (MRNA) United States $175.368B 54.17
Bristol Myers Squibb (BMY) United States $137.771B 9.17
Amgen (AMGN) United States $123.866B 13.41
CSL (CSLLY) Australia $102.597B 0.00
Gilead Sciences (GILD) United States $89.973B 8.70
BioNTech SE (BNTX) Germany $86.154B 18.59
Regeneron Pharmaceuticals (REGN) United States $69.735B 11.97
Illumina (ILMN) United States $65.997B 74.98
Vertex Pharmaceuticals (VRTX) United States $48.996B 19.04
Biogen (BIIB) United States $44.592B 12.24
BeiGene (BGNE) Cayman Islands $34.845B 0.00
Genmab (GMAB) Denmark $28.151B 69.13
Seagen (SGEN) United States $27.670B 46.65
Genmab (GNMSF) Denmark $27.591B 68.97
Horizon Therapeutics Public (HZNP) Ireland $23.961B 22.71
Bio-Rad Laboratories (BIO.B) United States $23.483B 50.05
Alnylam Pharmaceuticals (ALNY) United States $22.282B 0.00
Bio-Techne Corp (TECH) United States $20.698B 93.08
Exact Sciences (EXAS) United States $17.994B 0.00
Novavax (NVAX) United States $17.303B 0.00
ARGENX SE-ADR (ARGX) Netherlands $16.550B 0.00
Repligen (RGEN) United States $16.274B 124.02
Incyte (INCY) United States $16.218B 38.45
BioMarin Pharmaceutical (BMRN) United States $14.168B 101.67
Guardant Health (GH) United States $12.865B 0.00
QIAGEN (QGEN) Netherlands $12.195B 20.65
Zai Lab (ZLAB) China $11.901B 0.00
Intellia Therapeutics (NTLA) United States $11.055B 0.00
CureVac (CVAC) Germany $10.540B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $8.935B 22.95
Biohaven Pharmaceutical Holding (BHVN) United States $8.894B 0.00
Ascendis Pharma (ASND) Denmark $8.873B 0.00
Mirati Therapeutics (MRTX) United States $8.677B 0.00
SWEDISH ORP BIO (BIOVF) Sweden $8.417B 30.17
Acceleron Pharma (XLRN) United States $8.170B 0.00
Vir Biotechnology (VIR) United States $6.832B 0.00
Beam Therapeutics (BEAM) United States $6.775B 0.00
Sarepta Therapeutics (SRPT) United States $6.711B 0.00
Ultragenyx Pharmaceutical (RARE) United States $6.580B 0.00
Exelixis (EXEL) United States $6.449B 70.59
Denali Therapeutics (DNLI) United States $6.402B 181.48
Fate Therapeutics (FATE) United States $6.330B 0.00
Blueprint Medicines (BPMC) United States $6.076B 17.15
Halozyme Therapeutics (HALO) United States $5.871B 23.98
Legend Biotech (LEGN) United States $5.871B 0.00
NeoGenomics (NEO) United States $5.802B 786.33
Twist Bioscience (TWST) United States $5.568B 0.00
Certara (CERT) United States $5.524B 0.00
I-Mab (IMAB) China $5.243B 0.00
AbCellera Biologics (ABCL) $5.242B 0.00
Adaptive Biotechnologies (ADPT) United States $5.153B 0.00
Alkermes (ALKS) Ireland $4.951B 146.14
Arvinas (ARVN) United States $4.668B 0.00
Editas Medicine (EDIT) United States $4.116B 0.00
Reata Pharmaceuticals (RETA) United States $3.859B 0.00
Galapagos (GLPG) Belgium $3.634B 0.00
Arena Pharmaceuticals (ARNA) United States $3.609B 0.00
SpringWorks Therapeutics (SWTX) United States $3.544B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $3.470B 0.00
Kymera Therapeutics (KYMR) United States $3.317B 0.00
Prothena (PRTA) Ireland $3.305B 0.00
Insmed (INSM) United States $3.185B 0.00
ALX Oncology Holdings (ALXO) United States $3.154B 0.00
Emergent Biosolutions (EBS) United States $3.069B 7.40
Amicus Therapeutics (FOLD) United States $2.969B 0.00
Apellis Pharmaceuticals (APLS) United States $2.951B 0.00
Cytokinetics (CYTK) United States $2.814B 0.00
Intra-Cellular Therapies (ITCI) United States $2.723B 0.00
ACADIA Pharmaceuticals (ACAD) United States $2.554B 0.00
Myriad Genetics (MYGN) United States $2.554B 0.00
Seer (SEER) $2.493B 0.00
Instil Bio (TIL) United States $2.476B 0.00
Celldex Therapeutics (CLDX) United States $2.473B 0.00
Morphic Holding (MORF) United States $2.442B 0.00
Arcus Biosciences (RCUS) United States $2.382B 0.00
Vericel (VCEL) United States $2.378B 283.33
Sorrento Therapeutics (SRNE) United States $2.367B 0.00
C4 Therapeutics (CCCC) United States $2.364B 0.00
Ligand Pharmaceuticals (LGND) United States $2.266B 33.14
Protagonist Therapeutics (PTGX) United States $2.210B 0.00
Atea Pharmaceuticals (AVIR) United States $2.151B 0.00
Harmony Biosciences Holdings (HRMY) United States $2.072B 35.29
Amarin (AMRN) Ireland $2.040B 516.00
Myovant Sciences (MYOV) United Kingdom $2.010B 0.00
NGM Biopharmaceuticals (NGM) United States $1.983B 0.00
Alector (ALEC) United States $1.962B 0.00
REGENXBIO (RGNX) United States $1.924B 0.00
Revance Therapeutics (RVNC) United States $1.905B 0.00
Castle Biosciences (CSTL) United States $1.881B 0.00
ADC Therapeutics SA (ADCT) Switzerland $1.830B 0.00
Deciphera Pharmaceuticals (DCPH) United States $1.802B 0.00
Berkeley Lights (BLI) United States $1.786B 0.00
PHARMA MAR SA (PHMMF) Spain $1.737B 0.00
UniQure (QURE) Netherlands $1.676B 5.70
MorphoSys AG (MOR) Germany $1.671B 0.00
Dynavax Technologies (DVAX) United States $1.662B 0.00
Dicerna Pharmaceuticals (DRNA) United States $1.649B 0.00
Global Blood Therapeutics (GBT) United States $1.621B 0.00
Nurix Therapeutics (NRIX) United States $1.616B 0.00
Codexis (CDXS) United States $1.600B 0.00
Inovio Pharmaceuticals (INO) United States $1.592B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $1.563B 0.00
MaxCyte (MXCT) United States $1.541B 0.00
Zymeworks (ZYME) Canada $1.532B 0.00
Kadmon Holdings (KDMN) United States $1.517B 0.00
Ocugen (OCGN) United States $1.497B 0.00
Y-mAbs Therapeutics (YMAB) United States $1.475B 0.00
Bionano Genomics (BNGO) United States $1.474B 0.00
Travere Therapeutics (TVTX) United States $1.429B 0.00
Genetron Holdings (GTH) China $1.420B 0.00
PureTech Health (PRTC) United States $1.418B 0.00
Zealand Pharma (ZEAL) Denmark $1.398B 0.00
Immunocore Holdings (IMCR) United Kingdom $1.393B 0.00
Scholar Rock Holding (SRRK) United States $1.380B 0.00
Arcturus Therapeutics Holdings (ARCT) United States $1.377B 0.00
Inhibrx (INBX) United States $1.372B 0.00
Sangamo Therapeutics (SGMO) United States $1.331B 0.00
Agenus (AGEN) United States $1.253B 0.00
BioAtla (BCAB) United States $1.246B 0.00
Coherus BioSciences (CHRS) United States $1.208B 0.00
Bluebird Bio (BLUE) United States $1.203B 0.00
Avid Bioservices (CDMO) United States $1.169B 238.13
MannKind (MNKD) United States $1.166B 0.00
Repare Therapeutics (RPTX) Canada $1.143B 0.00
Forma Therapeutics Holdings (FMTX) United States $1.143B 0.00
Precigen (PGEN) United States $1.130B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $1.117B 0.00
RAPT THERAPTICS (RAPT) United States $1.105B 0.00
Fulcrum Therapeutics (FULC) United States $1.087B 0.00
Northwest Biotherapeutics (NWBO) United States $1.075B 0.00
ImmunityBio (IBRX) United States $1.046B 0.00
IDEAYA Biosciences (IDYA) United States $1.002B 0.00
Zealand Pharma (ZLDPF) Denmark $0.997B 0.00
Merus (MRUS) Netherlands $0.983B 0.00
Nkarta (NKTX) United States $0.968B 0.00
Prometheus Biosciences (RXDX) United States $0.949B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.941B 0.00
Sutro Biopharma (STRO) United States $0.922B 0.00
Immatics (IMTX) Germany $0.920B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.909B 28.17
BeyondSpring (BYSI) United States $0.898B 0.00
Avidity Biosciences (RNA) United States $0.862B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.843B 0.00
Shattuck Labs (STTK) United States $0.842B 0.00
Mesoblast (MESO) Australia $0.824B 0.00
VBI Vaccines (VBIV) United States $0.809B 0.00
Curis (CRIS) United States $0.765B 0.00
Precision BioSciences (DTIL) United States $0.741B 0.00
Cara Therapeutics (CARA) United States $0.740B 92.31
Keros Therapeutics (KROS) United States $0.728B 0.00
Amryt Pharma (AMYT) United Kingdom $0.717B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.711B 0.00
AnaptysBio (ANAB) United States $0.709B 0.00
Pliant Therapeutics (PLRX) United States $0.677B 0.00
Adagene (ADAG) China $0.665B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.656B 11.95
Mersana Therapeutics (MRSN) United States $0.646B 0.00
Sinovac Biotech (SVA) China $0.642B 6.47
Cellectis S.A (CLLS) France $0.636B 0.00
Brooklyn ImmunoTherapeutics (BTX) United States $0.633B 0.00
Gritstone Bio (GRTS) United States $0.632B 0.00
Ambrx Biopharma (AMAM) United States $0.629B 0.00
Pharming Group (PHAR) Netherlands $0.627B 0.00
MiMedx (MDXG) United States $0.626B 0.00
Affimed (AFMD) Germany $0.622B 0.00
Acumen Pharmaceuticals (ABOS) United States $0.620B 0.00
Akoya Biosciences (AKYA) United States $0.617B 0.00
Pharming Group (PHGUF) Netherlands $0.612B 24.44
Spero Therapeutics (SPRO) United States $0.596B 0.00
Bolt Biotherapeutics (BOLT) United States $0.595B 0.00
G1 THERAPEUTICS (GTHX) United States $0.590B 0.00
Seres Therapeutics (MCRB) United States $0.582B 0.00
Anika Therapeutics (ANIK) United States $0.574B 0.00
DBV Technologies S.A (DBVT) France $0.573B 0.00
MeiraGTx Holdings (MGTX) United States $0.569B 0.00
VistaGen Therapeutics (VTGN) United States $0.563B 0.00
ALBIREO PHARMA (ALBO) United States $0.563B 0.00
Vaccitech (VACC) United Kingdom $0.553B 0.00
Epizyme (EPZM) United States $0.550B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $0.527B 0.00
Clovis Oncology (CLVS) United States $0.527B 0.00
Inventiva S.A (IVA) France $0.522B 0.00
Intercept Pharmaceuticals (ICPT) United States $0.501B 0.00
AC Immune SA (ACIU) Switzerland $0.495B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.494B 0.00
Selecta Biosciences (SELB) United States $0.491B 0.00
Cel-Sci (CVM) United States $0.481B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.480B 0.00
XBiotech (XBIT) United States $0.479B 0.00
Verastem (VSTM) United States $0.461B 0.00
Clene (CLNN) United States $0.457B 0.00
ChromaDex (CDXC) United States $0.455B 0.00
Bellus Health (BLU) Canada $0.454B 0.00
Innate Pharma S.A (IPHA) France $0.442B 0.00
Geron (GERN) United States $0.436B 0.00
Oncobiologics (OTLK) United States $0.424B 0.00
Compugen (CGEN) Israel $0.419B 0.00
Arbutus Biopharma (ABUS) United States $0.418B 0.00
Lineage Cell Therapeutics (LCTX) United States $0.415B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.415B 0.00
BioDelivery Sciences (BDSI) United States $0.410B 12.61
Codiak BioSciences (CDAK) United States $0.403B 0.00
SQZ Biotechnologies (SQZ) United States $0.398B 0.00
Clearside Biomedical (CLSD) United States $0.391B 0.00
Starpharma Holdings (SPHRY) Australia $0.390B 0.00
Cue Biopharma (CUE) United States $0.382B 0.00
KaloBios Pharmaceuticals (HGEN) United States $0.381B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.371B 0.00
Athenex (ATNX) United States $0.371B 0.00
Cybin (CYBN) Canada $0.368B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.364B 0.00
Orchard Therapeutics (ORTX) United Kingdom $0.364B 0.00
ANI Pharmaceuticals (ANIP) United States $0.350B 9.54
Aeglea BioTherapeutics (AGLE) United States $0.343B 0.00
Theratechnologies (THTX) Canada $0.342B 0.00
Neoleukin Therapeutics (NLTX) United States $0.341B 0.00
Opthea (OPT) Australia $0.338B 0.00
Fortress Biotech (FBIO) United States $0.335B 0.00
Athersys (ATHX) United States $0.333B 0.00
Prima BioMed (IMMP) Australia $0.327B 0.00
Cogent Biosciences (COGT) United States $0.325B 0.00
Syros Pharmaceuticals (SYRS) United States $0.325B 0.00
CytomX Therapeutics (CTMX) United States $0.324B 0.00
Angion Biomedica (ANGN) United States $0.319B 0.00
INmune Bio (INMB) United States $0.312B 0.00
AquaBounty Technologies (AQB) United States $0.298B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.290B 0.00
Puma Biotechnology (PBYI) United States $0.284B 0.00
WAVE Life Sciences (WVE) Singapore $0.281B 0.00
XOMA (XOMA) United States $0.275B 115.81
Beyond Air (XAIR) United States $0.272B 0.00
Checkpoint Therapeutics (CKPT) United States $0.262B 0.00
Cardiff Oncology (CRDF) United States $0.259B 0.00
IBio (IBIO) United States $0.244B 0.00
Frequency Therapeutics (FREQ) United States $0.243B 0.00
Kamada (KMDA) Israel $0.239B 19.85
OVID THERAPEUTC (OVID) United States $0.235B 2.06
Paratek Pharmaceuticals (PRTK) United States $0.232B 0.00
Kaleido Biosciences (KLDO) $0.229B 0.00
Adicet Bio (ACET) United States $0.225B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.224B 0.00
Adverum Biotechnologies (ADVM) United States $0.213B 0.00
Seelos Therapeutics (SEEL) United States $0.203B 0.00
NextCure (NXTC) United States $0.201B 0.00
Trevena (TRVN) United States $0.201B 0.00
Kala Pharmaceuticals (KALA) United States $0.200B 0.00
Talis Biomedical (TLIS) United States $0.193B 0.00
OSMOTICA PHARM (OSMT) United States $0.185B 0.00
SESEN BIO, INC (SESN) United States $0.183B 0.00
TELA Bio (TELA) United States $0.181B 0.00
ObsEva SA (OBSV) Switzerland $0.176B 0.00
CorMedix Inc (CRMD) United States $0.176B 0.00
GENFIT S.A (GNFT) France $0.173B 0.00
VolitionRX (VNRX) United States $0.170B 0.00
Synlogic (SYBX) United States $0.166B 0.00
Enzo Biochem (ENZ) United States $0.165B 48.57
TScan Therapeutics (TCRX) United States $0.165B 0.00
HOOKIPA Pharma (HOOK) United States $0.164B 0.00
Aptinyx (APTX) United States $0.163B 0.00
POXEL SA FRANCE (PXXLF) France $0.161B 0.00
Galena Biopharma (SLS) United States $0.160B 0.00
ADMA Biologics Inc (ADMA) United States $0.159B 0.00
Catalyst Biosciences (CBIO) United States $0.159B 0.00
Erytech Pharma SA (ERYP) France $0.157B 0.00
LogicBio Therapeutics (LOGC) United States $0.146B 0.00
Dyadic (DYAI) United States $0.146B 0.00
Biofrontera AG (BFRA) Germany $0.145B 0.00
Vascular Biogenics (VBLT) Israel $0.145B 0.00
F-star Therapeutics (FSTX) United Kingdom $0.145B 0.00
ATyr Pharma (LIFE) United States $0.144B 0.00
VTv Therapeutics (VTVT) United States $0.144B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.144B 0.00
Strongbridge Biopharma (SBBP) United States $0.143B 0.00
Nicox SA (NICXF) France $0.142B 0.00
PHASEBIO PHARMA (PHAS) United States $0.141B 0.00
Applied Genetic Technologies (AGTC) United States $0.139B 0.00
Liquidia Technologies (LQDA) United States $0.138B 0.00
Novogen (KZIA) Australia $0.135B 0.00
Purple Biotech (PPBT) Israel $0.129B 0.00
Cyclerion Therapeutics (CYCN) United States $0.127B 0.00
Abeona Therapeutics (ABEO) United States $0.126B 0.00
Evofem Biosciences (EVFM) United States $0.123B 0.00
Eton Pharmaceuticals (ETON) United States $0.123B 0.00
Orgenesis (ORGS) United States $0.122B 248.00
X4 Pharmaceuticals (XFOR) United States $0.119B 0.00
Exicure (XCUR) United States $0.119B 0.00
Yumanity Therapeutics (YMTX) United States $0.118B 0.00
Eyenovia (EYEN) United States $0.116B 0.00
Leap Therapeutics (LPTX) United States $0.115B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.115B 0.00
Voyager Therapeutics (VYGR) United States $0.114B 6.54
Viridian Therapeutics (VRDN) United States $0.114B 0.00
Entera Bio (ENTX) Israel $0.109B 0.00
Palatin Technologies (PTN) United States $0.108B 0.00
Cidara Therapeutics (CDTX) United States $0.103B 0.00
Cocrystal Pharma (COCP) United States $0.103B 0.00
Armata Pharmaceuticals (ARMP) United States $0.097B 0.00
Pluristem Therapeutics (PSTI) Israel $0.095B 0.00
Aadi Bioscience (AADI) United States $0.090B 0.00
Celsion (CLSN) United States $0.089B 0.00
Lumos Pharma (LUMO) United States $0.088B 0.00
Aptevo Therapeutics (APVO) United States $0.084B 0.00
Adocia (ADOCY) France $0.083B 0.00
ARAVIVE, INC (ARAV) United States $0.081B 0.00
Zosano Pharma (ZSAN) United States $0.080B 0.00
Stealth BioTherapeutics (MITO) Cayman Islands $0.080B 0.00
Advaxis (ADXS) United States $0.080B 0.00
Liminal BioSciences (LMNL) Canada $0.078B 0.00
Aytu BioPharma (AYTU) United States $0.077B 0.00
AEterna Zentaris (AEZS) United States $0.075B 0.00
TRACON Pharmaceuticals (TCON) United States $0.074B 0.00
DiaMedica Therapeutics (DMAC) United States $0.073B 0.00
Edesa Biotech (EDSA) Canada $0.072B 0.00
Emmaus Life Sciences (EMMA) United States $0.071B 0.00
Evogene (EVGN) Israel $0.071B 0.00
Longeveron (LGVN) United States $0.070B 0.00
Celyad SA (CYAD) Belgium $0.069B 0.00
Vaccinex (VCNX) United States $0.069B 0.00
Vyant Bio (VYNT) United States $0.069B 0.00
AIkido Pharma (AIKI) United States $0.068B 0.00
ABVC BioPharma (ABVC) United States $0.067B 0.00
Organovo Holdings (ONVO) United States $0.065B 0.00
Protalix BioTherapeutics (PLX) Israel $0.061B 0.00
Enveric Biosciences (ENVB) United States $0.057B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.055B 0.00
Idera Pharmaceuticals (IDRA) United States $0.054B 0.00
AnPac Bio-Medical Science (ANPC) China $0.053B 0.00
Acorda Therapeutics (ACOR) United States $0.052B 1.08
Genetic Technologies (GENE) Australia $0.052B 0.00
Statera Biopharma (STAB) United States $0.050B 0.00
Vallon Pharmaceuticals (VLON) United States $0.049B 0.00
Forte Biosciences (FBRX) United States $0.049B 0.00
Windtree Therapeutics (WINT) United States $0.049B 0.00
ARIDIS PHARMACT (ARDS) United States $0.048B 0.00
BioCardia (BCDA) United States $0.048B 0.00
Soligenix (SNGX) United States $0.044B 0.00
Pulmatrix (PULM) United States $0.043B 0.00
Cyclo Therapeutics (CYTH) United States $0.042B 0.00
PLANET GREEN HOLDINGS CORP (PLAG) China $0.038B 0.00
Alimera Sciences (ALIM) United States $0.038B 0.00
Invo BioScience (INVO) United States $0.037B 0.00
Palisade Bio (PALI) United States $0.036B 0.00
Happiness Biotech Group (HAPP) China $0.035B 0.00
Timber Pharmaceuticals (TMBR) United States $0.033B 0.00
Lexaria Bioscience (LEXX) Canada $0.032B 0.00
ZIVO Bioscience (ZIVO) United States $0.031B 0.00
Benitec Biopharma (BNTC) United States $0.030B 0.00
Prana Biotechnology (ATHE) Australia $0.029B 0.00
GeoVax Labs (GOVX) United States $0.028B 0.00
IMMURON (IMRN) Australia $0.028B 0.00
ThermoGenesis Holdings (THMO) United States $0.027B 0.00
Titan Pharmaceuticals (TTNP) United States $0.020B 0.00
Sonnet BioTherapeutics Holdings (SONN) United States $0.016B 0.00
CollPlant Biotechnologies (CLGN) Israel $0.000B 0.00
PDL BioPharma (PDLI) United States $0.000B 0.00
UROGEN PHARMA (URGN) United States $0.000B 0.00